Why Our Speakers Are Excited About Cannabinoid Derived Pharmaceuticals Summit Europe
CEO and Co-Founder
"The Summit provides the invaluable opportunity to engage in thought provoking dialogue with others in order to better understand the issues in the pharmaceutical cannabinoid industry."
"I believe this conference will allow us insight into the future of drug development geared toward the endocannabinoid system and cannabinoid therapeutics, and hopefully highlight current research efforts to better understand practical applications of cannabinoid therapeutics."
International Research Center on Cannabis and Health
"The ability to reach a broader audience with our message outside of North America, especially as cannabinoid research is now a global phenomenon."
"The market is evolving at an ever-increasing pace. If the industry is struggling to find its feet then for consumers the world of cannabis is a minefield. As industry leaders, it’s our duty to work towards the creation of a simplified environment for consumers. Meetings such as this provide a potential platform to bring stakeholders together for that common cause."
CEO & Co-Founder
Professor & Chair of Biochemistry and Molecular Biology
University of Rome
"I believe that it is a real plus to put together basic scientists, medical doctors, producers and developers of cannabis-extracts as novel therapeutics, letting patients be part of the progress that the field is making at an amazing speed."